Switching IPL Manufacturers: What It Really Costs

Switching IPL manufacturers looks like a tooling decision. It turns out to be a certification project. The mold is the cheapest part of the move and the only part anyone puts in the comparison spreadsheet, which is why these switches blow their budget roughly nine times out of ten.

I’m Eric, co-founder of iShine. We’ve been the incoming factory on these moves and the outgoing one, which is where the estimate-versus-actual gap became obvious.

We’ve sat on both sides of this: as the incoming factory, and as the outgoing one when a brand moved elsewhere. The pattern is consistent. What the brand estimated was tooling. What actually consumed the year was certification.

Four switching costs that don’t make it into the comparison

Tooling. $20,000 to $50,000 for a housing set. Visible, quotable, and roughly correct from the first email.

Certification, when the legal manufacturer changes. This is the big one. An EU certificate of conformity names a specific legal manufacturer under Regulation (EU) 2017/745. It isn’t a product property you can carry between factories. If your new supplier becomes the legal manufacturer, that supplier needs its own technical file, its own quality system evidence, and its own conformity assessment — the existing certificate does not transfer.

Labeling, UDI and the GUDID record. In the US, the labeler of record changes the device identifier records. New DI, new GUDID entries, new label artwork. The establishment registration follows the new facility as well, which is a separate lookup in the FDA device listing database. In practice this means the packaging you printed for the old supplier is dead, even if the product inside is identical.

Inventory transition. The old supplier’s last run has to cover you until the new supplier’s first batch passes its own aging test and clears whatever certification step is in flight. That bridge is working capital, and it’s usually longer than the brand plans for.

Our piece on who carries GUDID responsibility in a private-label arrangement goes through the labeler question properly. Read it before you assume the record moves cleanly.

When you can reuse a report, and when you can’t

Here’s the distinction that saves or costs you six months.

A test report is evidence that a specific configuration, built by a specific party, met a specific standard. If the new factory builds the same configuration on the same equipment with the same components, a lab may accept a gap assessment instead of a full retest. That’s a commercial conversation with the lab, not a legal certainty.

What you cannot do is assume it. Ask the lab, in writing, before you sign with the new supplier. On the US side, whether a new 510(k) is required depends on who the specification developer is after the move.

The compliance stages in the validation services breakdown explain why this matters more as volume grows. At 3,000 to 5,000 units a month you’re typically in a 510(k) or MDR posture, and those approvals are pinned to the parties, not the plastic.

Running two factories during the switch

The sane way to switch is not to switch. It’s to overlap.

Place a final bridge order with the old supplier sized to cover the transition plus a safety margin. Qualify the new supplier with a small pilot batch that goes through full inspection and a portion of the aging test. Then, only once the pilot clears, release the first production order.

This costs more per unit during the overlap because both orders are sub-scale. It costs far less than a stockout, and a stockout during a peak season can end a brand’s year.

Put the switch on a calendar

The peak for home beauty devices sits in the run-up to Black Friday and then again before summer. Both are periods when you cannot afford to be mid-certification.

Work backwards: pick the sale date, subtract the certification window, subtract the pilot batch and its inspection, subtract the bridge inventory coverage. What’s left is the latest date you can start. If that date has passed, postpone the switch a quarter. A delayed switch costs margin. A switch that lands in November costs the season.

Our order calendar for peak seasons has the actual lead-time arithmetic, including how far ahead tooling has to be committed.

When switching is the wrong decision

Sometimes the right answer is to fix the relationship rather than replace it.

If the problem is unit price, a re-quote with a clearer cost breakdown often reveals that the “cheaper” alternative was quoting a smaller scope. We’ve seen brands go through a full switch and land within 4% of where they started.

If the problem is quality drift on one component, changing the component is easier than changing the factory.

If the problem is communication, a named account contact and a weekly call fixes more than a new supplier does.

The case for switching is strongest when the existing factory cannot produce the product you need at the volume you need, or when the paperwork doesn’t stand up, and that second one, once discovered, rarely gets better. The seven-document check applies to your current supplier as much as to a new one. Run it on who you already have. Some brands find the answer they needed without moving anything.

If you’re evaluating a move and want the certification question answered before you commit, send us the current certificate and the new BOM. We’ll tell you which parts of it survive and which don’t. On the Canadian side specifically, the MDL question has its own trap that catches brands mid-switch.

Part of IPL device sourcing: from first quote to mass production, which maps the five stages and where the schedule actually goes.

Sources

• Regulation (EU) 2017/745 (MDR) — defines the legal manufacturer a certificate is issued to
• GUDID — device identifier records tied to the labeler
• FDA establishment registration and device listing database — registration follows the new facility
• FDA 510(k) premarket notification database — whether a new clearance is required after a move